Clinical trials recruiting for Colitis, Ulcerative
33
Recruiting trials
36
US states with sites
48
Countries
6%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 10 |
| Florida | 9 |
| California | 8 |
| New York | 8 |
| Washington | 7 |
| Colorado | 6 |
| Georgia | 6 |
| North Carolina | 6 |
| Arizona | 5 |
| Illinois | 5 |
| Michigan | 5 |
| Ohio | 5 |
Top cities
New York, New York 8San Antonio, Texas 7Tacoma, Washington 7Chapel Hill, North Carolina 5Miami, Florida 5Southlake, Texas 5Atlanta, Georgia 4Colorado Springs, Colorado 4Houston, Texas 4Anaheim, California 3
Self-screener
Recruiting trials
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
- A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
- A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
- A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
- A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
- Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
- Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis
- Confirmatory Clinical Study in Active Ulcerative Colitis
- Diet Intervention Treatment for Active Ulcerative Colitis
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease
- Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
- JAK Inhibition in Ulcerative Colitis
- Magnesium in Gastrointestinal Disease
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
- Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases
- Therapeutic Endpoint in Pediatric IBD Conditions
Related conditions
Trials recruiting for Colitis, Ulcerative often also study these conditions. Each links to its own recruiting-trial list.
Ulcerative colitis 288Crohn's disease 328Inflammatory bowel disease 63Inflammatory Bowel Disease 15Psoriasis 233Obesity 1512Arthritis, Psoriatic 13Sleep Quality 12Rheumatoid arthritis 314Multiple sclerosis 445
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Colitis, Ulcerative trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.